Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 28, 16:00
2925.80
-142.85 (-4.66%)
VOLUME 43,448
LIVE
NSE
Feb 28, 16:01
2927.10
-139.95 (-4.56%)
VOLUME 1,659,956
News on Dr Reddys Laboratories
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's gets 2 observations from USFDA for formulation plant

5.25 pm | 28 Feb 2020 |  Source: PTI

In a regulatory filing, the drug major said the US Food and Drug Administration (USFDA) completed audit of its formulations manufacturing plant - 3 at...

Hot Stocks: 'Use rally in PSU bank and auto stocks to create fresh shorts'

8.32 am | 18 Feb 2020 |  Source: Moneycontrol.com

We advise focusing on defensives such as IT, Pharma and FMCG and select private banking majors for long trades...

Market Headstart: Nifty likely to consolidate further; avoid long positions for now 

8.25 am | 18 Feb 2020 |  Source: Moneycontrol.com

The index closed below 12,050 levels and formed bearish candle for the third straight session as closing was lower than opening value....

Dr Reddy’s hits 52-week high on zero observation for Andhra unit

1.05 pm | 17 Feb 2020 |  Source: Moneycontrol.com

The audit of company's Formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the USFDA, has been completed today with zero observation....

Will the Wockhardt move help Dr Reddy's break into the big league?

7.19 pm | 14 Feb 2020 |  Source: Moneycontrol.com

Analysts say unlike previous attempts, Dr Reddy’s is making more concerted effort to expand in India...

Indian pharma sector's growth slips to 7.6% in January, anti-diabetes segment a drag

8.19 pm | 10 Feb 2020 |  Source: Moneycontrol.com

The patents for Vildagliptin in India, held by Novartis, expired on December 9, opening the market for cheap rip-offs....

Stocks in the news: ACC, M&M, Yes Bank, Tata Steel, SAIL, Britannia, Cipla, Om Metals, MGL

7.47 am | 10 Feb 2020 |  Source: Moneycontrol.com

Oberoi Realty | ACC | J&K Bank | Om Metals and Bharat Forge are stocks, which are in news today....

Dr Reddy's launches Trientine Hydrochloride capsules in US

1.20 pm | 07 Feb 2020 |  Source: PTI

In a regulatory filing, Dr Reddy's Laboratories announced the launch of Trientine Hydrochloride capsules USP, 250 mg, a therapeutically equivalent...

Hold Dr Reddy's Laboratories target of Rs 3255: ICICI Direct

12.29 pm | 04 Feb 2020 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Dr Reddy's Laboratories with a target price of Rs 3255 in its research report dated January 28, 2020....

Dr Reddy's to expand product portfolio in US to fuel future growth

3.01 pm | 29 Jan 2020 |  Source: Moneycontrol.com

"We will not be dependent on any single product to grow...," said Erez Israeli, CEO of Dr Reddy's said....

Dr Reddys Labs Standalone December 2019 Net Sales at Rs 3,044.00 crore, up 11.43% Y-o-Y

2.20 pm | 29 Jan 2020 |  Source: Moneycontrol.com

NULL...

Dr Reddy’s Laboratories share price slips 2% on USFDA observations

10.00 am | 29 Jan 2020 |  Source: Moneycontrol.com

United States Food and Drug Administration (USFDA) issued a Form 483 with five observations to the company's API manufacturing plant at Srikakulam...

Dr Reddy's Labs reports strong operating performance in Q3: Key highlights from concall

6.49 pm | 28 Jan 2020 |  Source: Moneycontrol.com

The company has filed 20 formulations across the global markets, with three Abbreviated New Drug Application (ANDAs) in the US. It has filed 20 Drug M...

Dr Reddys Labs Standalone December 2019 Net Sales at Rs 3,044.00 crore, up 11.43% Y-o-Y

12.15 pm | 28 Jan 2020 |  Source: Moneycontrol.com

NULL...

Dr Reddys Labs Consolidated December 2019 Net Sales at Rs 4,397.10 crore, up 13.78% Y-o-Y

12.10 pm | 28 Jan 2020 |  Source: Moneycontrol.com

NULL...

Dr Reddy's hits over 3-year high as analysts remain positive, raise target post Q3 show

11.37 am | 28 Jan 2020 |  Source: Moneycontrol.com

HSBC also maintained buy call on the stock and raised price target to Rs 3,430 (from Rs 3,230 earlier)...

Dr Reddy's Labs share price rises 5% despite Rs 570 crore loss in Q3

3.57 pm | 27 Jan 2020 |  Source: Moneycontrol.com

Revenue from Europe, India and emerging markets rose 52 percent, 13 percent and 19 percent, respectively, on the back of new products and volume trans...

Dr Reddy's posts Rs 569.7 cr loss in Q3 on impairment of generic Nuvaring drug

12.28 pm | 27 Jan 2020 |  Source: Moneycontrol.com

Dr Reddy's Labs said in December 2019, there has been a generic launch and an authorized generic launch for the product Nuvaring, which has led to...

Dr Reddys Labs Standalone September 2019 Net Sales at Rs 3,446.00 crore, up 30.98% Y-o-Y

9.06 am | 04 Nov 2019 |  Source: Moneycontrol.com

NULL...

Dr Reddys Labs Consolidated September 2019 Net Sales at Rs 4,812.80 crore, up 26.07% Y-o-Y

9.02 am | 04 Nov 2019 |  Source: Moneycontrol.com

NULL...

1 2
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.